ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/15/2026
Back to search
Official data from USPTO
NANOTHERM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NANOTHERM
ST13
US500000086297568Class
1, 5, 10, 42, 44
Filing
86297568
Registration
5047640
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/16/2026
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
06/02/2014
Registration date
09/27/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2023
Last transaction
04/16/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
BERLIN, DE
Examiner
DOMBROW, COLLEEN M
Law office
L10
Holders and representatives
Holders
NANOTHERM THERAPEUTICS GMBH
MAGFORCE NT GMBH
MagForce AG
MagForce AG
Representatives
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productsmagnetic nanoparticles composed of iron oxide for use in industry and research; chemical metallic or magnetic particles and nanometer particles for use in industry and research; biopolymers containing metallic nanoparticles for use in industry and research; synthetic and natural oxides in the form of granules and granulates containing iron oxidein particular magnetite and maghemite; chemical products in the form of magnetic nanoparticlessuperparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles for use in industry and research; chemical preparations in the form of biocompatible polymer nanoparticlesliposomescoated nanoparticlesdrug-containing nanoparticlesall of the foregoing for use in industry and researchfor use in therapy methodsthermotherapy methodsthermoablation methods and/or hyperthermia methodsbut not including radiotherapy methods
Class 5
Diagnostic agents for medical purposesdiagnostic preparations for medical purposespharmaceuticalveterinary and medical preparations for the treatment of malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles comprising iron oxide; pharmaceutical preparations containing metallic or magnetic particles in the nature of nanoparticles for use as anticarcinogenic agents and/or antineoplastic agentsfor treating malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases ; contrasting agents for diagnostic imaging for medical purposes; none of the foregoing to be used with radiotherapy for cancer treatment
Class 10
Medical devices containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxidemagnetic powdersgranulesgranulates containing iron oxide for use in thermotherapy methodsthermoablation methods and/or hyperthermia methodsnone of the foregoing devices comprising compression equipment systems or apparatus or equipment for radiotherapy
Class 42
Medical and scientific research in the field of cancer and/or cardiovascular treatment and diagnosis; development and design of medical devices containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxideall for treatment and/or diagnosis of cancer and/or cardiovascular diseases ; providing medical testing and information in the field of cancer and cardiovascular research; none of the foregoing services comprising radiotherapy in cancer treatment
Class 44
Medical servicescancer and cardiovascular therapycancer and cardiovascular treatmentmedical diagnosis of cancer and cardiovascular diseases in the nature of dispensing of medical diagnostics and pharmaceutical and medical preparations containing magnetic particles; conducting medical device-based therapeutic or diagnostic methodsproviding physical therapy using magnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxide; medical servicestreatment of malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases ; medical servicesthermotherapeutic servicesthermoablation methods and/or hyperthermia methods for cancer and cardiovascular treatment using magnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles; providing medical testing for diagnostic or treatment purposes in the field of cancer and cardiovascular treatment; none of the foregoing services comprising radiotherapy in cancer treatment
Publications
History of USPTO decisions and trademark events.
39 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/08/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/27/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/22/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/22/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/22/2023
E815
TEAS SECTION 8 & 15 RECEIVED
03/22/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/27/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/30/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/14/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2015
GNRT
NON-FINAL ACTION E-MAILED
11/09/2015
CNRT
NON-FINAL ACTION WRITTEN
11/09/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/17/2015
GNRT
NON-FINAL ACTION E-MAILED
04/17/2015
CNRT
NON-FINAL ACTION WRITTEN
04/17/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2015
ALIE
ASSIGNED TO LIE
03/24/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2014
GNRT
NON-FINAL ACTION E-MAILED
09/15/2014
CNRT
NON-FINAL ACTION WRITTEN
09/15/2014
DOCK
ASSIGNED TO EXAMINER
09/15/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2014
NWAP
NEW APPLICATION ENTERED
06/05/2014
Continuous trademark protection
Get notified about every new filing that threatens NANOTHERM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.